 |
PDBsum entry 1urm
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Antioxidant enzyme
|
PDB id
|
|
|
|
1urm
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Crystal structure of the c47s mutant of human peroxiredoxin 5
|
 |
|
Authors
|
 |
C.Evrard,
A.Smeets,
B.Knoops,
J.P.Declercq.
|
 |
|
Ref.
|
 |
J Chem Cryst, 2004,
34,
553.
|
 |
 |
|
Secondary reference #1
|
 |
|
Title
|
 |
Crystal structure of human peroxiredoxin 5, A novel type of mammalian peroxiredoxin at 1.5 a resolution.
|
 |
|
Authors
|
 |
J.P.Declercq,
C.Evrard,
A.Clippe,
D.V.Stricht,
A.Bernard,
B.Knoops.
|
 |
|
Ref.
|
 |
J Mol Biol, 2001,
311,
751-759.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Overall view of the structure of PRDX5. (a)
Topological diagram showing the arrangement of the secondary
structural elements in PRDX5. The helices are represented as
cylinders and the b-strands as arrows. The beginning and the end
of the secondary structural elements are labelled. The three
helices and the four b-strands belonging to the thioredoxin fold
are colored green and red, respectively, while the remaining
elements are colored yellow. (b) and (c) Ribbon diagrams showing
the overall organization of PRDX5, colored as in (a). The two
orientations are nearly perpendicular, (c) being a top view of
(b). The side-chains of the three Cys residues are represented
as balls and sticks (Cys72 is hidden in (b)). Parts (b) and (c)
were prepared using MOLSCRIPT[26] and Raster3D. [27]
|
 |
Figure 2.
Figure 2. Structural comparisons with other peroxiredoxins.
Stereoscopic view of a superposition between the C^a traces of
PRDX5 (red) and (a) hORF6, (b) HBP23 (green). The orientation is
the same as in Figure 1(b). The Figures were produced using O.
[13]
|
 |
|
 |
 |
|
The above figures are
reproduced from the cited reference
with permission from Elsevier
|
 |
|
Secondary reference #2
|
 |
|
Title
|
 |
A twinned monoclinic crystal form of human peroxiredoxin 5 with eight molecules in the asymmetric unit.
|
 |
|
Authors
|
 |
J.P.Declercq,
C.Evrard.
|
 |
|
Ref.
|
 |
Acta Crystallogr D Biol Crystallogr, 2001,
57,
1829-1835.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2 The self-rotation function after detwinning, contoured
at 1 and
represented in orthonormal axes with x parallel to a and z
parallel to c*. (a) Twofold NCS rotation; (b) fourfold NCS
rotation.
|
 |
Figure 3.
Figure 3 Stereoscopic view projected along b showing a global
superposition of the eight molecules present in the asymmetric
unit of the monoclinic crystal form (red) with eight
symmetry-related molecules of the tetragonal form (green). The a
axis is horizontal and c* is vertical. The A chain is on the
bottom left of the figure and the H chain on the top right. The
figure was produced with O (Jones et al., 1991[Jones, T. A.,
Zou, J.-Y., Cowan, S. W. & Kjeldgaard, M. (1991). Acta Cryst.
A47, 110-119.]).
|
 |
|
 |
 |
|
The above figures are
reproduced from the cited reference
with permission from the IUCr
|
 |
|
Secondary reference #3
|
 |
|
Title
|
 |
Cloning and characterization of aoeb166, A novel mammalian antioxidant enzyme of the peroxiredoxin family.
|
 |
|
Authors
|
 |
B.Knoops,
A.Clippe,
C.Bogard,
K.Arsalane,
R.Wattiez,
C.Hermans,
E.Duconseille,
P.Falmagne,
A.Bernard.
|
 |
|
Ref.
|
 |
J Biol Chem, 1999,
274,
30451-30458.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Analysis of AOEB166 gene expression in human
tissues and cell lines. A, human multiple tissue Northern blot
(CLONTECH) containing approximately 2 µg of poly(A^+) RNA
of different tissue origins was analyzed for the presence of
human AOEB166 mRNA. B, Northern blot containing 40 µg/lane
of total RNA from human cell lines of different tissue origins
was also hybridized with human AOEB166 cDNA probe. Cell lines
were Caco-2 human colonic adenocarcinoma cell line, MRC-5 human
fetal lung fibroblast cell line, ECV-304 human endothelial cell
line, MDA-231 human breast cancer cell line, MCF-7 human breast
cancer cell line, THP-1 human monocytic leukemia cell line,
HT-29 human colonic adenocarcinoma cell line, LS174T human
colonic adenocarcinoma cell line, T47D human breast cancer cell
line, and HepG2 human hepatoblastoma cell line. Positions for
4.4 and 1.35 kilobases as marked by ribosomal markers are
indicated. Both blots were stripped of the hAOEB166 probe and
rehybridized with a human -actin probe
to assess integrity and levels of RNA between lanes (small
panels below each blot). C, quantitation of AOEB166 mRNA levels
in human master dot blot (CLONTECH). The dot blot, containing
poly(A^+) RNA normalized to the mRNA expression levels of eight
different housekeeping genes, was hybridized with AOEB166 cDNA
probe. mRNA levels were quantitated using phosphorimaging
technology. Higher levels are detected in thyroid gland and at
lower levels in pancreas. Yeast S. cerevisiae mRNA was used as
negative control.
|
 |
Figure 6.
Fig. 6. Peroxidase activity of recombinant hAOEB166.
Time-dependent removal of H[2]O[2] (A) or TBHP ( B) by
recombinant hAOEB166. The reaction mixture (200 µl)
contained 50 mM Hepes-NaOH, pH 7.4, 2 mM DTT, 1 mM H[2]O[2] or
800 µM TBHP, and recombinant hAOEB166 (0.2 mg/ml). At the
indicated times, the remaining concentration of H[2]O[2] or TBHP
was measured in 20 µl of reaction mixture with ferrous
ammonium sulfate/potassium thiocyanate and compared with
standards. The reduction of H[2]O[2] or TBHP in absence of
AOEB166 was also measured (none). Data are the means of
duplicate experiments.
|
 |
|
 |
 |
|
The above figures are
reproduced from the cited reference
with permission from the ASBMB
|
 |
|
|
|
|
 |